Raily Aesthetic Medicine International Holdings Balance Sheet Health
Financial Health criteria checks 4/6
Raily Aesthetic Medicine International Holdings has a total shareholder equity of CN¥150.5M and total debt of CN¥15.0M, which brings its debt-to-equity ratio to 10%. Its total assets and total liabilities are CN¥324.9M and CN¥174.3M respectively.
Key information
10.0%
Debt to equity ratio
CN¥15.00m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥40.85m |
| Equity | CN¥150.55m |
| Total liabilities | CN¥174.34m |
| Total assets | CN¥324.89m |
Recent financial health updates
No updates
Recent updates
Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Held Back By Insufficient Growth Even After Shares Climb 37%
Oct 02
Benign Growth For Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Underpins Its Share Price
Jul 22Revenues Working Against Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Share Price Following 47% Dive
Apr 22Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Stock Rockets 39% As Investors Are Less Pessimistic Than Expected
Feb 07Raily Aesthetic Medicine International Holdings Limited's (HKG:2135) Popularity With Investors Is Under Threat From Overpricing
Dec 19Raily Aesthetic Medicine International Holdings Limited (HKG:2135) Investors Are Less Pessimistic Than Expected
Aug 22Statutory Profit Doesn't Reflect How Good Raily Aesthetic Medicine International Holdings' (HKG:2135) Earnings Are
Sep 17Financial Position Analysis
Short Term Liabilities: 2135's short term assets (CN¥98.9M) do not cover its short term liabilities (CN¥137.8M).
Long Term Liabilities: 2135's short term assets (CN¥98.9M) exceed its long term liabilities (CN¥36.6M).
Debt to Equity History and Analysis
Debt Level: 2135 has more cash than its total debt.
Reducing Debt: 2135's debt to equity ratio has increased from 9.2% to 10% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2135 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 2135 has sufficient cash runway for 1.3 years if free cash flow continues to reduce at historical rates of 51.6% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 22:34 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Raily Aesthetic Medicine International Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|